RLBGX
Price
$35.65
Change
-$0.31 (-0.86%)
Updated
Jun 13 closing price
Net Assets
244.39B
RPBAX
Price
$27.58
Change
-$0.25 (-0.90%)
Updated
Jun 13 closing price
Net Assets
4.73B
Interact to see
Advertisement

RLBGX vs RPBAX

Header iconRLBGX vs RPBAX Comparison
Open Charts RLBGX vs RPBAXBanner chart's image
American Funds American Balanced R6
Price$35.65
Change-$0.31 (-0.86%)
VolumeN/A
Net Assets244.39B
T. Rowe Price Balanced
Price$27.58
Change-$0.25 (-0.90%)
VolumeN/A
Net Assets4.73B
RLBGX vs RPBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLBGX vs. RPBAX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBGX is a Buy and RPBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 244B vs. RPBAX (4.73B). RLBGX pays higher dividends than RPBAX: RLBGX (2.23) vs RPBAX (2.01). RLBGX was incepted earlier than RPBAX: RLBGX (16 years) vs RPBAX (86 years). RPBAX (0.65) is less costly to investors than RLBGX (0.25). RLBGX is a more actively managed with annual turnover of: 44.00 vs. RPBAX (39.20). RLBGX has a lower initial minimum investment than RPBAX: RLBGX (250) vs RPBAX (2500). RLBGX annual gain was more profitable for investors over the last year : 5.63 vs. RPBAX (3.81). RLBGX return over 5 years is better than : 40.35 vs. RPBAX (24.38).
RLBGXRPBAXRLBGX / RPBAX
Total Expense Ratio0.250.6042%
Annual Report Gross Expense Ratio0.250.6538%
Fund Existence16 years86 years-
Gain YTD4.5925.38885%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets244B4.73B5,161%
Annual Yield % from dividends2.232.01111%
Returns for 1 year5.633.81148%
Returns for 3 years33.7828.55118%
Returns for 5 years40.3524.38165%
Returns for 10 years60.8737.11164%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCCC1.680.06
+3.70%
C4 Therapeutics
PNTG27.67-0.07
-0.25%
Pennant Group (The)
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
GSAT21.95-0.24
-1.08%
Globalstar Inc
KTTA0.79-0.04
-5.21%
Pasithea Therapeutics Corp